why choose us

Clinical Trials Search

Showing 15,590 of 132,656 result(s)
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery

Status: Completed

Condition: Pelvic Organ Prolapse

Interventions: Randomly picked (like the flip of a coin) by a computer to receive either platelet-rich plasma (PRP) or normal saline.
This is a double-blind stu

Date: 2023-01-26

ZN-c3 in Adult Participants With Metastatic Colorectal Cancer

Status: Completed

Condition: Metastatic Colorectal Cancer

Interventions: ZN-c3 tablet by mouth, in combination with encorafenib

Date: 2023-01-26

Millipede AspiRation for Revascularization in Stroke (MARRS) Study

Status: Completed

Condition: Acute Ischemic Stroke

Interventions: Mechanical thrombectomy

Date: 2023-01-26

A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed;Refractory Acute Myeloid Leukemia

Status: Completed

Condition: Acute Myeloid Leukaemia

Interventions: Cell suspension, by intraveneous (IV) injection

Date: 2023-01-26

Red Light Photobiomodulation and Topical Disinfectants

Status: COMPLETED

Condition: Healthcare Associated Infection

Interventions:

All subjects will have a baseline sample taken of their nasal microbiome and undergo the administration of the following:

- Methylene Blue (0

Date: 2023-01-26

The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency

Status: Completed

Condition: Ectonucleotide Pyrophosphatase;phosphodiesterase1 Deficiency

Interventions: Recombinant fusion protein that contains the extracellular domains of human ENPP1 coupled with an Fc fragment from an immunoglobulin gamma-1 (IgG1) an

Date: 2023-01-26

Effects of Beef Consumption on Skeletal Muscle Protein Homeostasis and Inflammatory Factors in Pre- and Postmenopausal Females

Status: Completed

Condition: Menopause Related Conditions

Interventions: an omnivorous diet

Date: 2023-01-26

A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis

Status: Completed

Condition: Myelofibrosis Due to and Following Polycythemia Vera

Interventions: 10mg BID or 15mg BID

Date: 2023-01-26

A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

Status: Completed

Condition: Primary Immunodeficiency Diseases (PID)

Interventions: Participants will receive SC infusion of TAK-881.

Date: 2023-01-26